SRGN and metastatic malignant neoplasm in the lymph nodes: Notably, high expression of SRGN was found in 65.8% (25/38) of lymph node metastasis samples, versus 44.7% (17/38) of primary tumors, which suggests that SRGN might be involved in metastasis.